Healthcare · Pharmaceutical expenditure

Pharmaceutical expenditure in Australia in 2026

Australia's pharmaceutical expenditure in 2026 reached 2 % GDP of GDP, placing the country 12-th out of 197. This figure reflects a balanced policy: the government's Pharmaceutical Benefits Scheme (PBS) subsidizes a wide range of medicines, making them affordable while strictly controlling prices. The high share of spending is driven by growing demand for innovative drugs and an aging population, particularly in coastal urban agglomerations.

Data for 2026 · unit: % GDP
Position

Australia world ranking

#12 / 197

Country position on the scale from last to first place for this indicator.

AU
#12
#197#1
Trend

Change over time

Change in indicator over the available period.

1.50
1990
1.70
2000
1.90
2010
1.80
2020
2.00
2026

Values — % GDP

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical expenditure in Australia — how much?
Based on 2026 data — 2 % GDP. This is rank #12 out of 197 countries.
What is Australia's rank by Pharmaceutical expenditure?
Australia ranks #12 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Australia?
Over the available period the indicator changed from 1.50 to 2 % GDP.